ClinicalTrials.govpublic full text
Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome
covid19, cytokine release syndrome, nlrp3, dapansutrile, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 913328
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.